OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Growing concerns about using hypoxia-inducible factor prolyl hydroxylase inhibitors for the treatment of renal anemia
Takeshi Nakanishi, Takahiro Kuragano
Clinical Kidney Journal (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 8
Takeshi Nakanishi, Takahiro Kuragano
Clinical Kidney Journal (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 8
Showing 8 citing articles:
Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies
Alexander J. Kula
Pediatric Drugs (2025)
Closed Access
Alexander J. Kula
Pediatric Drugs (2025)
Closed Access
Novel and Cost-Effective Manufacturing Process Development of Daprodustat
Amarendhar Manda, Debjit Basu, Pavani Sankar Reddy, et al.
Organic Process Research & Development (2025)
Closed Access
Amarendhar Manda, Debjit Basu, Pavani Sankar Reddy, et al.
Organic Process Research & Development (2025)
Closed Access
Potential Roles of Hypoxia-Inducible Factor-1 in Alzheimer’s Disease: Beneficial or Detrimental?
Tsu‐Kung Lin, Chi-Ren Huang, Kai-Jung Lin, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 2
Tsu‐Kung Lin, Chi-Ren Huang, Kai-Jung Lin, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1378-1378
Open Access | Times Cited: 2
Uremic Toxins and Inflammation: Metabolic Pathways Affected in Patients Undergoing Renal Replacement Therapies
María Peris‐Fernández, Marta Roca, Julià L. Amengual, et al.
(2024)
Open Access | Times Cited: 1
María Peris‐Fernández, Marta Roca, Julià L. Amengual, et al.
(2024)
Open Access | Times Cited: 1
Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Mario Thevis, Tiia Kuuranne, Hans Geyer
Drug Testing and Analysis (2024)
Open Access | Times Cited: 1
Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis
Mengxue Yuan, Xinping Chen, Ruilin Ou, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 11, pp. 3559-3568
Closed Access
Mengxue Yuan, Xinping Chen, Ruilin Ou, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 11, pp. 3559-3568
Closed Access
Testosterone-induced erythrocytosis in transgender males: challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs
Azmi Mohammed, Yaasir Mamoojee, Richard Quinton
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 5, pp. 101930-101930
Closed Access
Azmi Mohammed, Yaasir Mamoojee, Richard Quinton
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 5, pp. 101930-101930
Closed Access
Metabolic Pathways Affected in Patients Undergoing Hemodialysis and Their Relationship with Inflammation
María Peris‐Fernández, Marta Roca, Julià L. Amengual, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9364-9364
Open Access
María Peris‐Fernández, Marta Roca, Julià L. Amengual, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9364-9364
Open Access
Desidustat: a novel PHD inhibitor for the treatment of CKD-induced anemia
Amit Joharapurkar, Vrajesh B. Pandya, Harilal Patel, et al.
Frontiers in Nephrology (2024) Vol. 4
Open Access
Amit Joharapurkar, Vrajesh B. Pandya, Harilal Patel, et al.
Frontiers in Nephrology (2024) Vol. 4
Open Access
